A study that contained nine normal cortex, 22 diffuse astrocytoma, and 15 GBM samples showed that high levels of STAT5B were detected in 57.1% of GBM samples, 27.3% of diffuse astrocytoma samples, and 22.2% of normal cortex samples. This evidence concerns the gene STAT5B and glioblastoma.